1. Home
  2. PMN vs MOVE Comparison

PMN vs MOVE Comparison

Compare PMN & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMN
  • MOVE
  • Stock Information
  • Founded
  • PMN 2004
  • MOVE 2018
  • Country
  • PMN Canada
  • MOVE United States
  • Employees
  • PMN N/A
  • MOVE N/A
  • Industry
  • PMN Pharmaceuticals and Biotechnology
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PMN Health Care
  • MOVE Health Care
  • Exchange
  • PMN Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • PMN 32.3M
  • MOVE 25.9M
  • IPO Year
  • PMN N/A
  • MOVE 2021
  • Fundamental
  • Price
  • PMN $0.92
  • MOVE $5.77
  • Analyst Decision
  • PMN
  • MOVE Buy
  • Analyst Count
  • PMN 0
  • MOVE 1
  • Target Price
  • PMN N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • PMN 80.8K
  • MOVE 89.9K
  • Earning Date
  • PMN 12-31-2024
  • MOVE 11-14-2024
  • Dividend Yield
  • PMN N/A
  • MOVE N/A
  • EPS Growth
  • PMN N/A
  • MOVE N/A
  • EPS
  • PMN N/A
  • MOVE N/A
  • Revenue
  • PMN N/A
  • MOVE $902,000.00
  • Revenue This Year
  • PMN N/A
  • MOVE N/A
  • Revenue Next Year
  • PMN N/A
  • MOVE $545.31
  • P/E Ratio
  • PMN N/A
  • MOVE N/A
  • Revenue Growth
  • PMN N/A
  • MOVE N/A
  • 52 Week Low
  • PMN $0.87
  • MOVE $2.80
  • 52 Week High
  • PMN $3.10
  • MOVE $12.75
  • Technical
  • Relative Strength Index (RSI)
  • PMN 45.09
  • MOVE 54.55
  • Support Level
  • PMN $0.87
  • MOVE $4.80
  • Resistance Level
  • PMN $0.94
  • MOVE $6.24
  • Average True Range (ATR)
  • PMN 0.07
  • MOVE 0.47
  • MACD
  • PMN -0.00
  • MOVE -0.07
  • Stochastic Oscillator
  • PMN 31.31
  • MOVE 39.35

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: